From: Membrane androgen binding sites are preferentially expressed in human prostate carcinoma cells
Kind of surgery | Specimen No | Prostate cancer | Gleason Score | Hyperplasia | Specific testosterone Binding (log scale) |
---|---|---|---|---|---|
Radical | 1 | + | (4+4) 8 | - | 0,6532 |
Prostatectomy | 2 | + | (4+4) 8 | - | 0,5772 |
" | 7 | + | (4+3) 7 | - | 0,7112 |
" | 11 | - | Â | + | 0,359 |
" | 13 | - | Â | + | 0,176 |
" | 14 | + | (3+4) 7 | - | 0,77 |
" | 15 | + | (3+4) 7 | - | 0,014 |
" | 20 | + | (3+5) 8 | - | 0,439 |
" | 35 | + | (3+4) 7 | - | 0,6 |
" | 36 | + | (3+4) 7 | - | 0,74 |
" | 38 | + | (3+4) 7 | - | 0,57 |
" | 40 | + | (3+3) 6 | - | 0,5698 |
" | 9* | - | Â | + | 0,5314 |
" | 10* | - | Â | + | 0,447 |
Transurethral Resection | 3 | - | Â | + | 0,397 |
 | 4 | - |  | + | 0,39 |
" | 5 | - | Â | + | 0,221 |
" | 6 | + | - | Â | 0,509 |
" | 16 | + | (3+2) 5 | - | 0,67 |
" | 17 | - | Â | + | 0,096 |
" | 18 | - | Â | + | 0,23 |
" | 19 | - | Â | + | 0,143 |
" | 29 | - | Â | - | 0,12 |
" | 30 | - | Â | - | 0,02 |
" | 33 | - | Â | + | 0,079 |
" | 34 | - | Â | + | 0,3 |
Radical Prostatectomy (non-malignant) | 8 | - | Â | - | 0,398 |
- | 12 | - | Â | - | 0,038 |
- | 21 | - | Â | - | 0,166 |
" | 22 | - | Â | - | 0,259 |
" | 32 | - | Â | - | 0,034 |
" | 37 | - | Â | - | 0,52 |
" | 39 | - | Â | - | 0,268 |
" | 41 | - | Â | - | 0,367 |